US 11981724
DNA antibody constructs for use against middle east respiratory syndrome coronavirus
granted A61KA61K2039/53A61K39/42
Quick answer
US patent 11981724 (DNA antibody constructs for use against middle east respiratory syndrome coronavirus) held by Inovio Pharmaceuticals, Inc. expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/53, A61K39/42